Last updated: February 28, 2025
Sponsor: University Hospital of North Norway
Overall Status: Active - Recruiting
Phase
4
Condition
Urologic Cancer
Prostate Cancer, Early, Recurrent
Prostate Cancer
Treatment
Placebo
Spinal Anesthesia with Bupivacaine
Clinical Study ID
NCT06860893
Prostate REK 866656
Ages 18-80 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Prostate cancer
Exclusion
Exclusion Criteria:
- Benign prostate disease
Study Design
Total Participants: 30
Treatment Group(s): 2
Primary Treatment: Placebo
Phase: 4
Study Start date:
February 23, 2025
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
University Hospital of North Norway
Tromso, 9038
NorwayActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.